Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.16B |
| 2 |
Hershey
HSY
|
+$663M |
| 3 |
Lockheed Martin
LMT
|
+$622M |
| 4 |
Altria Group
MO
|
+$525M |
| 5 |
Pfizer
PFE
|
+$499M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.76B |
| 2 |
Merck
MRK
|
+$2.35B |
| 3 |
Automatic Data Processing
ADP
|
+$1.57B |
| 4 |
Blackstone
BX
|
+$1.38B |
| 5 |
Illinois Tool Works
ITW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.85% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.72% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2976
Inogen
INGN
$182M
| $564K | ﹤0.01% |
69,941
| – | – |
|
2977
Commercial Vehicle Group
CVGI
$155M
| $558K | ﹤0.01% |
86,851
| – | – |
|
2978
Future Fuel
FF
$214M
| $557K | ﹤0.01% |
69,165
| – | – |
|
2979
FVCBankcorp
FVCB
$339M
| $557K | ﹤0.01% |
45,710
| – | – |
|
2980
Greene County Bancorp
GCBC
$587M
| $555K | ﹤0.01% |
19,282
| – | – |
|
2981
ESS Tech
GWH
$21.7M
| $555K | ﹤0.01% |
51,115
+982
| +2% | +$13.4K |
|
2982
Acrivon Therapeutics
ACRV
$65.5M
| $553K | ﹤0.01% |
77,382
+8,881
| +13% | +$41.2K |
|
2983
Ring Energy
REI
$317M
| $552K | ﹤0.01% |
281,454
| – | – |
|
2984
Destination XL Group
DXLG
$30.6M
| $551K | ﹤0.01% |
152,988
| – | – |
|
2985
American Coastal Insurance
ACIC
$527M
| $547K | ﹤0.01% |
51,210
| – | – |
|
|
BLFY
2986
DELISTED
Blue Foundry Bancorp
BLFY
| $547K | ﹤0.01% |
58,467
-4,417
| -7% | -$41.5K |
|
2987
Elbit Systems
ESLT
$38.8B
| $546K | ﹤0.01% |
2,599
+810
| +45% | +$169K |
|
|
TTSH
2988
DELISTED
Tile Shop Holdings
TTSH
| $546K | ﹤0.01% |
77,663
-4,416
| -5% | -$29.8K |
|
2989
Weyco Group
WEYS
$384M
| $545K | ﹤0.01% |
17,093
| – | – |
|
2990
Nathan's Famous
NATH
$403M
| $544K | ﹤0.01% |
7,682
| – | – |
|
2991
Plumas Bancorp
PLBC
$427M
| $543K | ﹤0.01% |
14,770
| – | – |
|
2992
Norwood Financial Corp
NWFL
$374M
| $542K | ﹤0.01% |
19,937
| – | – |
|
2993
Timberland Bancorp
TSBK
$355M
| $542K | ﹤0.01% |
20,143
-700
| -3% | -$19.3K |
|
2994
Lineage Cell Therapeutics
LCTX
$274M
| $542K | ﹤0.01% |
365,952
+2,737
| +0.8% | +$3.1K |
|
2995
Alico
ALCO
$284M
| $541K | ﹤0.01% |
18,485
| – | – |
|
|
KG
2996
Kestrel Group
KG
$69.2M
| $541K | ﹤0.01% |
12,022
| – | – |
|
2997
BioXcel Therapeutics
BTAI
$26.3M
| $539K | ﹤0.01% |
11,936
+217
| +2% | +$10.4K |
|
2998
Ooma
OOMA
$592M
| $538K | ﹤0.01% |
63,094
-35,822
| -36% | -$356K |
|
2999
Karat Packaging
KRT
$826M
| $534K | ﹤0.01% |
18,667
| – | – |
|
|
CWBC
3000
Community West Bancshares
CWBC
$692M
| $534K | ﹤0.01% |
26,843
| – | – |
|
Similar funds
Charles Schwab's Q1 2024 Portfolio in Review
As of Q1 2024, Charles Schwab held 3,573 positions worth $433B, up 10% from $394B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3.8%. Charles Schwab opened 35 new positions and exited 102, leaving the 3,573-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2024 buy was Schwab Fundamental US Large Company Index ETF: 3,608,604 shares worth $81.1M.
- Charles Schwab added most to Bristol-Myers Squibb in Q1 2024, an estimated $2.16B increase.
- Charles Schwab's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.76B.
- Charles Schwab fully exited Splunk Inc in Q1 2024, selling an estimated $104M.
- Charles Schwab's ten largest holdings make up 20% of its $433B portfolio in Q1 2024.
- Charles Schwab opened 35 new positions and closed 102 in Q1 2024.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $433B.
Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.